SERPINB6 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to SERPINB6 Antibody

SERPINB6 antibodies are immunoreagents designed to detect SERPINB6, a 42 kDa intracellular serine protease inhibitor. These antibodies enable the study of SERPINB6’s function in inhibiting proteases like cathepsin G, thrombin, and chymotrypsin, which are implicated in inflammation, coagulation, and lysosomal stability .

Role in Hearing Loss

A truncating mutation (p.E245X) in SERPINB6 causes autosomal-recessive nonsyndromic sensorineural hearing loss (DFNB91). Key findings include:

  • Loss of Protein Expression: Homozygous mutants showed absent SERPINB6 protein in leukocytes via Western blot .

  • Inner Ear Localization: SERPINB6 is expressed in cochlear and vestibular hair cells, where it protects against lysosomal enzyme leakage during stress .

  • Mechanism: SERPINB6 deficiency leads to unchecked protease activity, causing hair cell apoptosis .

Cellular Stress and Lysosomal Stability

  • Lysosomal Integrity: SERPINB6 overexpression in HeLa cells reduced lysosomal rupture under osmotic stress, as shown by LysoTracker assays .

  • Cytoprotection: SERPINB6 inhibits cathepsin G and kallikreins, preventing necrosis during oxidative or hypoxic stress .

Coagulation and Inflammation

  • Thrombin Inhibition: SERPINB6 (placental thrombin inhibitor) modulates coagulation by binding thrombin’s active site .

  • Senescent Cells: SILAC analysis revealed increased SERPINB6 secretion in senescent cells, linking it to age-related hemostatic changes .

Table 2: Validation Data

ApplicationProteintech 14962-1-AP Assay Genie CAB9944
Western BlotDetected in HeLa, MCF-7, mouse liverConfirmed in HeLa, mouse/rat liver
ImmunohistochemistryHuman skeletal muscle (1:20–1:200)Not reported
ImmunoprecipitationValidated in human placenta tissueNot reported

Recommended Protocols:

  • Western Blot: Use RIPA buffer for extraction, 10% SDS-PAGE, and transfer to PVDF membranes .

  • IHC: Antigen retrieval with TE buffer (pH 9.0) enhances signal in formalin-fixed tissues .

Clinical and Therapeutic Implications

  • Hearing Loss: SERPINB6 mutations are a biomarker for congenital deafness, with potential gene therapy applications .

  • Inflammatory Diseases: Targeting SERPINB6 could modulate protease-driven pathologies like rheumatoid arthritis or thrombosis .

Product Specs

Buffer
PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. Store at -20°C. Avoid freeze-thaw cycles.
Lead Time
Typically, we can ship your orders within 1-3 business days after receiving them. Delivery time may vary depending on the purchase method or location. Please contact your local distributor for specific delivery timelines.
Synonyms
CAP antibody; Cytoplasmic antiproteinase antibody; Peptidase inhibitor 6 antibody; PI-6 antibody; PI6 antibody; Placental thrombin inhibitor antibody; Protease inhibitor 6 (placental thrombin inhibitor) antibody; PTI antibody; Serpin B6 antibody; SERPINB6 antibody; SPB6_HUMAN antibody
Target Names
SERPINB6
Uniprot No.

Target Background

Function
SERPINB6 may play a regulatory role in serine proteinases found in the brain or those that have leaked from the bloodstream. It functions as an inhibitor of cathepsin G, kallikrein-8, and thrombin. This protein is believed to have a crucial role in the inner ear, protecting against the leakage of lysosomal content during stress. Loss of this protective function can lead to cell death and sensorineural hearing loss.
Gene References Into Functions
  • A truncating mutation in SERPINB6 is associated with autosomal-recessive nonsyndromic sensorineural hearing loss. PMID: 20451170
  • In mast cells, SERPINB6 regulates the activity of endogenous beta-tryptase in the cytoplasm. PMID: 14670919
  • SERPINB6 is expressed in developing gonads and in both somatic and germ cells of adult gonads. PMID: 16175637
  • SERPINB6 protects the intracellular compartment of keratinocytes from ectopic kallikrein-8. PMID: 17761692
  • Research has indicated that overexpression of GPD1 and RRBP1 proteins, along with a lack of expression of HNRNPH1 and SERPINB6 proteins, may serve as new candidate biomarkers for colon cancer. PMID: 19425502

Show More

Hide All

Database Links

HGNC: 8950

OMIM: 173321

KEGG: hsa:5269

STRING: 9606.ENSP00000338358

UniGene: Hs.519523

Involvement In Disease
Deafness, autosomal recessive, 91 (DFNB91)
Protein Families
Serpin family, Ov-serpin subfamily
Subcellular Location
Cytoplasm.
Tissue Specificity
Expressed in keratinocytes (at protein level). Highest levels in skeletal muscle. Also found in placenta, cardiac muscle, lung, liver, kidney and pancreas. Expressed in the inner ear hair cells. Expressed abundantly by normal mast cells in different tissu

Q&A

What is SERPINB6 and why is it important in research?

SERPINB6 is a serine protease inhibitor belonging to the ovalbumin-serpin subfamily. It plays significant roles in regulating proteolytic processes within cells, particularly inhibiting cathepsin G, kallikrein-8, and thrombin . SERPINB6 is crucial for maintaining cellular integrity by safeguarding vital intracellular components from degradation by serine proteases, especially during stress responses . Research interest in SERPINB6 has increased due to its association with nonsyndromic progressive hearing loss, suggesting its protective role in inner ear hair cells against lysosomal content leakage during stress .

What types of SERPINB6 antibodies are available for research?

Several types of SERPINB6 antibodies are available for research purposes:

Antibody TypeHost SpeciesApplicationsTarget SpeciesExamples
PolyclonalRabbitWB, IHC, ELISAHuman, Mouse, Ratab97330, CAB9944, ab233229
MonoclonalMouseWB, IP, IF, IHC, ELISAMouse, Ratsc-374535 (F-5)

These antibodies target different epitopes of SERPINB6, with some recognizing specific regions (e.g., amino acids 50-300 or 180-300) while others target the full-length protein .

What is the molecular weight of SERPINB6 protein in Western blot applications?

SERPINB6 typically appears at approximately 42-43 kDa in Western blot applications . The predicted band size is 43 kDa, which aligns with the observed molecular weight in experimental conditions. When performing Western blot validation, researchers should expect to see a clear band at this molecular weight, though slight variations may occur depending on post-translational modifications or the specific tissue/cell type being analyzed .

What are the optimal applications for SERPINB6 antibodies in research?

SERPINB6 antibodies have been validated for multiple experimental applications with varying degrees of effectiveness:

ApplicationRecommended DilutionNotes
Western Blot (WB)1:500-1:18000Most consistently reliable application across antibodies
Immunohistochemistry (IHC-P)1:20-1:200Effective for paraffin-embedded tissues
Immunofluorescence (IF/ICC)1:50-1:500Works well for cellular localization studies
Immunoprecipitation (IP)0.5-4.0 μg per 1-3 mg proteinEffective for protein-protein interaction studies
ELISAVariousAntibody-dependent

The optimal application may vary depending on the specific antibody, and titration is recommended when using a new antibody to determine the best working conditions for each experimental system .

How should SERPINB6 antibodies be stored to maintain activity?

For optimal antibody performance and longevity, SERPINB6 antibodies should be stored according to the following guidelines:

  • As supplied: 12 months from date of receipt at -20°C to -70°C

  • After reconstitution:

    • 1 month at 2-8°C under sterile conditions

    • 6 months at -20°C to -70°C under sterile conditions

  • For liquid antibody formulations: Store at -20°C, aliquoting is recommended to avoid repeated freeze-thaw cycles

  • Some formulations contain preservatives like 0.02% sodium azide and 50% glycerol at pH 7.3

Proper storage is critical to maintaining antibody specificity and sensitivity in experimental applications.

How can researchers differentiate between SERPINB6 isoforms or closely related family members?

Distinguishing between SERPINB6 isoforms and related family members requires careful antibody selection and experimental design:

  • Select epitope-specific antibodies: Choose antibodies targeting unique regions of SERPINB6 not conserved in other family members.

  • Use species-specific antibodies: Consider that in mice, the SERPINB6 gene family consists of three distinct genes (SERPINB6a, SERPINB6b, SERPINB6c) , while humans have multiple potential isoforms with variable N-terminal regions .

  • Perform validation experiments: Include appropriate positive and negative controls, along with knockout or knockdown samples if available.

  • Complementary approaches: Combine antibody-based detection with PCR-based methods to identify specific transcript variants.

  • Mass spectrometry validation: For absolute confirmation of protein identity, consider peptide sequencing.

When studying mouse models, note that mouse SERPINB6 shares 76% amino acid identity with human SERPINB6 , which may affect cross-reactivity of some antibodies.

What are the appropriate sample preparation methods for SERPINB6 detection in different applications?

Optimal sample preparation varies by application and sample type:

For Western Blot:

  • Use standard cell lysis buffers containing protease inhibitors

  • Recommended protein loading: 10-30 μg of total protein per lane

  • Denature samples at 95°C for 5 minutes in reducing sample buffer

  • Expected molecular weight: 42-43 kDa

For Immunohistochemistry:

  • Paraffin-embedded sections: Antigen retrieval with TE buffer pH 9.0 is often recommended

  • Alternatively, citrate buffer pH 6.0 may be used for antigen retrieval

  • Antibody concentration: ~20 μg/ml has been validated for DAB staining

  • Multiple tissue types have been validated, including prostate, kidney, liver, and cerebrum

For Immunofluorescence:

  • Fix cells with 4% paraformaldehyde for 10-15 minutes

  • Permeabilize with 0.1-0.5% Triton X-100

  • Block with 1-5% BSA or normal serum

  • Incubate with primary antibody at appropriate dilution (typically 1:50-1:500)

How can researchers troubleshoot non-specific binding or weak signal when using SERPINB6 antibodies?

When facing issues with SERPINB6 antibody performance, consider these troubleshooting approaches:

For Weak Signal:

  • Optimize antibody concentration: Perform a titration experiment using a range of concentrations

  • Extend incubation time: Consider overnight incubation at 4°C for primary antibody

  • Enhance detection sensitivity: Use signal amplification systems or more sensitive detection methods

  • Improve antigen retrieval: Test different antigen retrieval buffers and conditions

  • Check protein expression: Verify SERPINB6 expression in your specific sample type

For Non-specific Binding:

  • Increase blocking stringency: Use 5% BSA or normal serum from the same species as the secondary antibody

  • Optimize washing steps: Increase washing duration and frequency

  • Pre-adsorb antibody: Pre-incubate with a blocking peptide if available

  • Reduce antibody concentration: Lower the primary antibody concentration

  • Validate with multiple antibodies: Use antibodies targeting different epitopes to confirm specificity

What is the significance of SERPINB6 in hearing loss research, and how can antibodies contribute to this field?

SERPINB6 has been linked to nonsyndromic progressive hearing loss (DFNB91), making it an important target in auditory research . Mutations in this gene affect the protection against lysosomal content leakage in inner ear hair cells during stress .

Antibodies can contribute to this research in several ways:

  • Localization studies: Immunohistochemistry can reveal SERPINB6 distribution in the inner ear

  • Protein interaction studies: Immunoprecipitation can identify binding partners relevant to hearing mechanisms

  • Expression analysis: Western blotting can quantify expression changes in disease models

  • Structural studies: Antibodies can help purify protein for structural analysis

  • Therapeutic development: Understanding SERPINB6's role could lead to targeted therapies

Researchers should select antibodies that have been validated in inner ear tissues or cell models relevant to hearing research. Combined approaches using both antibody-based detection and genetic models can provide comprehensive insights into SERPINB6's role in hearing physiology and pathology.

How should researchers interpret SERPINB6 expression patterns across different tissues and disease states?

When analyzing SERPINB6 expression patterns:

  • Establish baseline expression: SERPINB6 is highly expressed in skeletal muscle, with significant expression in placenta, cardiac muscle, lung, liver, kidney, pancreas, and inner ear hair cells .

  • Consider cell-type specificity: Expression has been detected in keratinocytes, monocytes, mast cells (including mastocytoma lesions), and capillary endothelial cells .

  • Evaluate disease relevance:

    • In hearing loss: Monitor changes in inner ear expression

    • In inflammatory conditions: Assess expression in monocytes and granulocytes

    • In cancer studies: Compare expression between normal and tumor tissues

  • Account for species differences:

    • Human SERPINB6 is a single gene with multiple potential isoforms

    • Mouse models have three distinct genes (SERPINB6a, SERPINB6b, SERPINB6c)

  • Quantitative analysis: Use appropriate normalization controls and consider both transcriptional and post-translational regulation.

What controls should be included in experiments using SERPINB6 antibodies?

For rigorous experimental design with SERPINB6 antibodies, include these controls:

Positive Controls:

  • Tissues with known high expression: Skeletal muscle, placenta

  • Cell lines with validated expression: HeLa, HepG2, MCF-7

  • Recombinant SERPINB6 protein (for Western blot ladder control)

Negative Controls:

  • Primary antibody omission control

  • Isotype control (matching the primary antibody class)

  • Tissues known to have minimal SERPINB6 expression

  • SERPINB6 knockdown or knockout samples (if available)

Specificity Controls:

  • Peptide competition assay using the immunizing peptide

  • Multiple antibodies targeting different epitopes of SERPINB6

  • Detection with secondary antibody alone

Including these controls helps validate results and ensures proper interpretation of SERPINB6 detection in experimental systems.

How can researchers effectively combine SERPINB6 antibody-based detection with other methodologies for comprehensive studies?

An integrated multi-methodology approach enhances SERPINB6 research:

  • Complementary protein detection methods:

    • Combine antibody-based methods (Western blot, IHC, IF) with mass spectrometry for definitive protein identification

    • Use proximity ligation assay (PLA) to study protein-protein interactions in situ

  • Transcriptional analysis integration:

    • Correlate protein detection with RT-PCR or RNA-seq data to understand transcriptional regulation

    • Single-cell approaches can reveal cell-type specific expression patterns

  • Functional studies:

    • Combine antibody detection with enzyme activity assays to correlate SERPINB6 presence with protease inhibition

    • Use cell-based assays to assess the functional impact of SERPINB6 expression changes

  • Genetic approaches:

    • Integrate CRISPR/Cas9 gene editing with antibody detection to study specific mutations

    • Correlate genotype with protein expression patterns in clinical samples

  • Imaging techniques:

    • Combine immunofluorescence with live-cell imaging to study dynamic processes

    • Super-resolution microscopy can reveal detailed subcellular localization

This multifaceted approach provides more robust data and comprehensive understanding of SERPINB6 biology than any single method alone.

What are the emerging applications of SERPINB6 antibodies in cancer and inflammatory disease research?

SERPINB6 research is expanding into cancer and inflammatory disease areas:

In cancer research, SERPINB6 antibodies are being used to:

  • Evaluate expression in various tumor types, including prostate cancer and glioma

  • Study the protein's role in tumor progression and metastasis

  • Investigate connections to serine protease activity in the tumor microenvironment

  • Examine its potential as a biomarker for specific cancer subtypes

In inflammatory disease research:

  • SERPINB6 interacts with proteases found in monocytes and granulocytes, including cathepsin G

  • It forms stable complexes with these proteases, modulating inflammatory responses

  • Antibody-based detection can help track SERPINB6's role in acute and chronic inflammation

  • The protein's cytoplasmic localization allows unique regulation of intracellular proteolytic processes

Single-cell transcriptomics has recently revealed early molecular and immune alterations involving SERPINB6 in the serrated neoplasia pathway toward colorectal cancer , suggesting new research directions.

How can researchers optimize co-localization studies using SERPINB6 antibodies with other cellular markers?

For effective co-localization studies:

  • Antibody selection considerations:

    • Choose antibodies raised in different host species to allow simultaneous detection

    • Verify that antibody pairs have compatible fixation requirements

    • Select antibodies with validated performance in immunofluorescence applications

    • Consider using directly conjugated antibodies to reduce cross-reactivity

  • Sample preparation optimization:

    • Test different fixation methods (paraformaldehyde, methanol, or combined approaches)

    • Optimize permeabilization conditions for intracellular access

    • Use sequential detection for challenging combinations

    • Consider antigen retrieval impact on epitope preservation

  • Imaging parameters:

    • Use appropriate filters to minimize spectral overlap

    • Perform sequential scanning for confocal microscopy

    • Include single-stained controls for setting acquisition parameters

    • Consider super-resolution techniques for detailed co-localization analysis

  • Analysis approaches:

    • Employ quantitative co-localization metrics (Pearson's coefficient, Manders' coefficients)

    • Use software tools designed for co-localization analysis

    • Perform z-stack imaging to ensure true co-localization in three dimensions

    • Consider live-cell imaging for dynamic interaction studies

What are the most promising techniques for studying SERPINB6 protein-protein interactions and their functional significance?

Several advanced techniques can effectively study SERPINB6 interactions:

  • Co-immunoprecipitation (Co-IP):

    • Multiple SERPINB6 antibodies have been validated for IP applications

    • Can identify native protein complexes in cellular contexts

    • Best performed with antibodies recognizing different epitopes than potential binding regions

  • Proximity Ligation Assay (PLA):

    • Allows visualization of protein interactions (<40nm) in situ

    • Provides spatial information about where interactions occur within cells

    • Can detect transient or weak interactions missed by traditional methods

  • FRET/BRET approaches:

    • Enable real-time monitoring of dynamic interactions

    • Can be performed in living cells

    • Provide quantitative data on interaction kinetics

  • Mass spectrometry-based interactomics:

    • Antibody-based pull-downs coupled with MS analysis

    • Identifies multiple interaction partners simultaneously

    • Can reveal previously unknown interactions

  • Structural studies:

    • X-ray crystallography or cryo-EM of SERPINB6-protease complexes

    • Provides atomic-level details of interaction mechanisms

    • Helps understand the unique inhibitory mechanism of SERPINB6

Understanding these interactions is particularly important given SERPINB6's known binding to proteases like cathepsin G, kallikrein-8, and thrombin , which underlie its protective functions in various tissues.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.